{"id":"https://openalex.org/W2158478263","doi":"https://doi.org/10.3389/fonc.2013.00206","title":"Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group Study","display_name":"Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group Study","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2158478263","doi":"https://doi.org/10.3389/fonc.2013.00206","mag":"2158478263","pmid":"https://pubmed.ncbi.nlm.nih.gov/23964347"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2013.00206","doi":"https://doi.org/10.3389/fonc.2013.00206","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2013.00206","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2013.00206/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fonc.2013.00206/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088715850","display_name":"Chunqiao Tian","orcid":"https://orcid.org/0000-0003-3815-8025","observed_orcids":["https://orcid.org/0000-0003-3815-8025"]},"institutions":[{"id":"https://openalex.org/I117693200","display_name":"Gynecologic Oncology Group","ror":"https://ror.org/04x187e69","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I117693200"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chunqiao Q. Tian","raw_affiliation_strings":["Gynecologic Oncology Group Statistical and Data Center , Buffalom, NY , USA","Gynecologic Oncology Group Statistical and Data Center, Buffalom, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecologic Oncology Group Statistical and Data Center , Buffalom, NY , USA","institution_ids":[]},{"raw_affiliation_string":"Gynecologic Oncology Group Statistical and Data Center, Buffalom, NY, USA","institution_ids":["https://openalex.org/I117693200"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085457452","display_name":"Kathleen M. Darcy","orcid":"https://orcid.org/0000-0003-2888-2968","observed_orcids":["https://orcid.org/0000-0003-2888-2968"]},"institutions":[{"id":"https://openalex.org/I116530498","display_name":"Inova Health System","ror":"https://ror.org/04mrb6c22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I116530498"]},{"id":"https://openalex.org/I117693200","display_name":"Gynecologic Oncology Group","ror":"https://ror.org/04x187e69","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I117693200"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen M. Darcy","raw_affiliation_strings":["Women\u2019s Health Integrated Research Center at Inova Health System, DOD Gynecologic Cancer Center of Excellence, 3289 Woodburn Road, Suite 370, Annandale, 22003, VA, United States","Gynecologic Oncology Group Statistical and Data Center, Buffalom, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Women\u2019s Health Integrated Research Center at Inova Health System, DOD Gynecologic Cancer Center of Excellence, 3289 Woodburn Road, Suite 370, Annandale, 22003, VA, United States","institution_ids":["https://openalex.org/I116530498"]},{"raw_affiliation_string":"Gynecologic Oncology Group Statistical and Data Center, Buffalom, NY, USA","institution_ids":["https://openalex.org/I117693200"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002154444","display_name":"Thomas C. Krivak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I2799629232","display_name":"Western Pennsylvania Hospital","ror":"https://ror.org/02yhx1447","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799629232"]},{"id":"https://openalex.org/I4210106153","display_name":"Magee-Womens Hospital","ror":"https://ror.org/01fbdn283","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210106153","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas C. Krivak","raw_affiliation_strings":["Western Pennsylvania Gynecological Oncology, 7011 Crider Road, Mars, 16046, PA, United States","Magee Womens Hospital, University of Pittsburgh, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Western Pennsylvania Gynecological Oncology, 7011 Crider Road, Mars, 16046, PA, United States","institution_ids":["https://openalex.org/I2799629232"]},{"raw_affiliation_string":"Magee Womens Hospital, University of Pittsburgh, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I170201317","https://openalex.org/I4210106153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011275523","display_name":"Julie A. DeLoia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie A. DeLoia","raw_affiliation_strings":["Georgetown University , Washington , DC , USA","Georgetown University, Washington, DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Georgetown University , Washington , DC , USA","institution_ids":["https://openalex.org/I184565670"]},{"raw_affiliation_string":"Georgetown University, Washington, DC, USA","institution_ids":["https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090143508","display_name":"Deborah Kay Armstrong","orcid":"https://orcid.org/0000-0003-0852-803X","observed_orcids":["https://orcid.org/0000-0003-0852-803X"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah Armstrong","raw_affiliation_strings":["John Hopkins Kimmel Cancer Center , Baltimore , MD , USA","John Hopkins Kimmel Cancer Center, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Hopkins Kimmel Cancer Center , Baltimore , MD , USA","institution_ids":["https://openalex.org/I145311948"]},{"raw_affiliation_string":"John Hopkins Kimmel Cancer Center, Baltimore, MD, USA","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003277934","display_name":"Warren Davis","orcid":"https://orcid.org/0000-0002-8700-5693","observed_orcids":["https://orcid.org/0000-0002-8700-5693"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Warren Davis","raw_affiliation_strings":["Department of Cancer Prevention and Control , Roswell Park Cancer Institute , Buffalo , NY , USA","Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Prevention and Control , Roswell Park Cancer Institute , Buffalo , NY , USA","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034055316","display_name":"Hua Zhao","orcid":"https://orcid.org/0000-0002-1629-8695","observed_orcids":["https://orcid.org/0000-0002-1629-8695"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hua Zhao","raw_affiliation_strings":["Department of Cancer Prevention and Control , Roswell Park Cancer Institute , Buffalo , NY , USA","Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Prevention and Control , Roswell Park Cancer Institute , Buffalo , NY , USA","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057283450","display_name":"Kirsten B. Moysich","orcid":"https://orcid.org/0000-0002-4678-2058","observed_orcids":["https://orcid.org/0000-0002-4678-2058"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kirsten Moysich","raw_affiliation_strings":["Department of Cancer Prevention and Control , Roswell Park Cancer Institute , Buffalo , NY , USA","Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Prevention and Control , Roswell Park Cancer Institute , Buffalo , NY , USA","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036294770","display_name":"Christine B. Ambrosone","orcid":"https://orcid.org/0000-0003-1717-9943","observed_orcids":["https://orcid.org/0000-0003-1717-9943"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christine B. Ambrosone","raw_affiliation_strings":["Roswell Park Cancer Institute, Department of Cancer Prevention and Control, Elm & Carlton Streets, Buffalo, 14263, NY, United States","Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roswell Park Cancer Institute, Department of Cancer Prevention and Control, Elm & Carlton Streets, Buffalo, 14263, NY, United States","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA","institution_ids":["https://openalex.org/I1292894508"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5036294770"],"corresponding_institution_ids":["https://openalex.org/I1292894508"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.6063,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.71514553,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"3","issue":null,"first_page":"206","last_page":"206"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brca1","display_name":"BRCA1","score":0.8939999938011169},{"id":"https://openalex.org/keywords/brca2","display_name":"BRCA2","score":1.0},{"id":"https://openalex.org/keywords/single-nucleotide-polymorphisms","display_name":"single nucleotide polymorphisms","score":0.8410000205039978},{"id":"https://openalex.org/keywords/epithelial-ovarian-cancer","display_name":"epithelial ovarian cancer","score":0.9330000281333923},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7760000228881836},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.8569999933242798},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/platinum-sensitivity","display_name":"platinum sensitivity","score":0.6010000109672546},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.796999990940094},{"id":"https://openalex.org/keywords/african-american-patients","display_name":"African American patients","score":0.5299999713897705},{"id":"https://openalex.org/keywords/germline-mutations","display_name":"germline mutations","score":0.6819999814033508},{"id":"https://openalex.org/keywords/gynecologic-oncology-group","display_name":"Gynecologic Oncology Group","score":0.7229999899864197}],"concepts":[{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.7724692821502686},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.7705330848693848},{"id":"https://openalex.org/C2780435969","wikidata":"https://www.wikidata.org/wiki/Q5625186","display_name":"Gynecologic oncology","level":2,"score":0.7698477506637573},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.7694925665855408},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.7558972835540771},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.677248477935791},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6663453578948975},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5267302989959717},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.37324559688568115},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32678651809692383}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fonc.2013.00206","doi":"https://doi.org/10.3389/fonc.2013.00206","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2013.00206","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2013.00206/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmid:23964347","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23964347","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:2738865","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3740480","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3740480","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3740480","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:64312593db65413da75c9366acacc254","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/64312593db65413da75c9366acacc254","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 3 (2013)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2013.00206","doi":"https://doi.org/10.3389/fonc.2013.00206","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2013.00206","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2013.00206/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.4699999988079071,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G215985982","display_name":null,"funder_award_id":"#P30 CA016056","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5996839100","display_name":null,"funder_award_id":"U10CA027469","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8494369300","display_name":null,"funder_award_id":"U10 CA037517","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000888465","display_name":"Roswell Park Cancer Center Support Grant","funder_award_id":"5p30ca016056-48","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2158478263.pdf","grobid_xml":"https://content.openalex.org/works/W2158478263.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W114319471","https://openalex.org/W1576826397","https://openalex.org/W1894955529","https://openalex.org/W1981932411","https://openalex.org/W1984353922","https://openalex.org/W1984431444","https://openalex.org/W1992015449","https://openalex.org/W1998258610","https://openalex.org/W2000197817","https://openalex.org/W2014988936","https://openalex.org/W2019604831","https://openalex.org/W2059000312","https://openalex.org/W2071842647","https://openalex.org/W2072345776","https://openalex.org/W2078320712","https://openalex.org/W2085546635","https://openalex.org/W2087025655","https://openalex.org/W2096791553","https://openalex.org/W2102004732","https://openalex.org/W2106830870","https://openalex.org/W2115954319","https://openalex.org/W2118324079","https://openalex.org/W2119036591","https://openalex.org/W2123322249","https://openalex.org/W2124322375","https://openalex.org/W2124392685","https://openalex.org/W2133597315","https://openalex.org/W2133712354","https://openalex.org/W2142397500","https://openalex.org/W2142460765","https://openalex.org/W2143934748","https://openalex.org/W2144154516","https://openalex.org/W2144261670","https://openalex.org/W2147539392","https://openalex.org/W2154175915","https://openalex.org/W2157855880","https://openalex.org/W2158985391","https://openalex.org/W2160446928","https://openalex.org/W2164432834","https://openalex.org/W2168077502","https://openalex.org/W2169102956","https://openalex.org/W2328421677","https://openalex.org/W2329417450","https://openalex.org/W2956031965","https://openalex.org/W4288400169","https://openalex.org/W4298324324","https://openalex.org/W6922416790"],"related_works":["https://openalex.org/W3147219444","https://openalex.org/W3149674127","https://openalex.org/W2316397280","https://openalex.org/W2091461259","https://openalex.org/W2053380829","https://openalex.org/W2030595392","https://openalex.org/W3152185824","https://openalex.org/W2053306150","https://openalex.org/W4385496679","https://openalex.org/W1987294960"],"abstract_inverted_index":{"PURPOSE:":[0],"BRCA1/BRCA2":[1,20,33],"germline":[2,206],"mutations":[3],"appear":[4],"to":[5,160,271],"enhance":[6],"the":[7,14,128,138,208],"platinum-sensitivity,":[8],"but":[9],"little":[10],"is":[11,262],"known":[12,204],"about":[13],"prognostic":[15],"relevance":[16],"of":[17,32,56,187,243],"polymorphisms":[18,104,130],"in":[19,21,44,70,76,277,281,292],"epithelial":[22],"ovarian":[23],"cancer":[24],"(EOC).":[25],"This":[26],"study":[27],"evaluated":[28],"whether":[29],"common":[30],"variants":[31],"are":[34],"associated":[35,181,286],"with":[36,46,85,92,182,203,287,294,301],"progression-free":[37],"survival":[38,42],"(PFS)":[39],"and":[40,62,97,105,114,133,152,164,175,226,252,257,260,303],"overall":[41],"(OS)":[43],"patients":[45,202,248],"advanced":[47],"stage":[48,88,297],"sporadic":[49],"EOC.":[50],"EXPERIMENTAL":[51],"DESIGN:":[52],"The":[53,221],"allelic":[54],"frequency":[55],"BRCA1":[57,141,205,224,278],"(2612C":[58],">":[59,65],"T,":[60],"P871L-rs799917)":[61],"BRCA2":[63,244,267,282],"(114A":[64],"C,":[66],"N372H-rs144848)":[67],"were":[68,109,117,180,284],"determined":[69],"normal":[71],"blood":[72],"DNA":[73],"from":[74,131],"women":[75,116,293],"Gynecologic":[77],"Oncology":[78],"Group":[79],"protocol":[80],"#172":[81],"phase":[82],"III":[83,89,298],"trial":[84],"optimally":[86,295],"resected":[87],"EOC":[90,299],"treated":[91,300],"intraperitoneal":[93],"or":[94,107,273,280,290],"intravenous":[95],"cisplatin":[96,302],"paclitaxel":[98],"(C":[99],"+":[100],"P).":[101],"Associations":[102],"between":[103,223],"PFS":[106,157,272,289],"OS":[108,227,291],"assessed.":[110],"RESULTS:":[111],"Two":[112],"hundred":[113],"thirty-two":[115],"included":[118],"for":[119,127,140,147,150,154,170,254],"analyses.":[120],"African":[121],"Americans":[122],"(AA)":[123],"had":[124],"different":[125],"distributions":[126],"two":[129],"Caucasians":[132],"others.":[134],"For":[135],"non-AA":[136,247],"patients,":[137],"genotype":[139],"P871L":[142,225,279],"was":[143,158,212,228,249,269],"distributed":[144],"as":[145],"38%":[146],"CC,":[148,258],"49%":[149],"CT,":[151],"13%":[153],"TT.":[155],"Median":[156],"estimated":[159],"be":[161],"31,":[162],"21,":[163],"21":[165],"months,":[166],"respectively.":[167],"After":[168,199],"adjusting":[169],"cell":[171],"type,":[172],"residual":[173],"disease,":[174],"chemotherapy":[176],"regimen,":[177],"CT/TT":[178],"genotypes":[179],"a":[183],"1.40-fold":[184],"increased":[185],"risk":[186],"disease":[188],"progression":[189],"[95%":[190],"confidence":[191],"interval":[192],"(CI)":[193],"=":[194,197,216,219,232,236,239],"1.00-1.95,":[195],"p":[196,218,238],"0.049].":[198],"removing":[200],"seven":[201],"mutations,":[207],"hazard":[209],"ratio":[210],"(HR)":[211],"1.36":[213],"(95%":[214],"CI":[215,235],"0.97-1.91,":[217],"0.073).":[220],"association":[222],"not":[229,285],"significant":[230],"(HR":[231],"1.25,":[233],"95%":[234],"0.88-1.76,":[237],"0.212).":[240],"Genotype":[241],"distribution":[242],"N372H":[245,283],"among":[246],"50,":[250],"44,":[251],"6%":[253],"AA,":[255],"AC,":[256],"respectively":[259],"there":[261],"no":[263],"evidence":[264],"that":[265],"this":[266],"polymorphism":[268],"related":[270],"OS.":[274],"CONCLUSION:":[275],"Polymorphisms":[276],"either":[288],"resected,":[296],"paclitaxel.":[304]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}